Sharon Downing

发表

Eculizumab improves fatigue in refractory generalized myasthenia gravis

K. Patra, P. van Damme, M. Benatar, 2019, Quality of Life Research.

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.

G. L. Masson, W. Löscher, P. Vermersch, 2017, The Lancet. Neurology.

Death with Dignity in Washington and Oregon Patients with Amyotrophic Lateral Sclerosis (P1.140)

M. Weiss, J. Benditt, L. Henson, 2016 .

Achillea millefolium L.

Sharon Downing, 1983 .

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

P. van Damme, M. Benatar, F. Piehl, 2019, Journal of the Neurological Sciences.

Death with dignity in Washington patients with amyotrophic lateral sclerosis

M. Weiss, J. Benditt, Susan E. Strom, 2016, Neurology.

Death with dignity inWashington patients with amyotrophic lateral sclerosis

M. Weiss, J. Benditt, L. Henson, 2022 .

‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

P. van Damme, M. Benatar, F. Piehl, 2020, Journal of Neurology.

A Survey of Expressive Communication Skills in Children With Angelman Syndrome

Robin L. Alvares, Sharon Downing, 1998 .